BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2024 7:03:25 AM | Browse: 46 | Download: 178
 |
Received |
|
2024-08-05 06:26 |
 |
Peer-Review Started |
|
2024-08-05 06:26 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-18 03:27 |
 |
Revised |
|
2024-09-24 01:45 |
 |
Second Decision |
|
2024-10-09 02:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-09 08:02 |
 |
Articles in Press |
|
2024-10-09 08:02 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-10-12 02:26 |
 |
Publish the Manuscript Online |
|
2024-10-21 07:03 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Letter to the Editor |
Article Title |
Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Xiao-Xia Qiu and Zheng Li |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Zheng Li, PhD, Jiangsu Engineering Research Center of Cardiovascular Drugs Targeting Endothelial Cells, College of Health Sciences, School of Life Sciences, Jiangsu Normal University, No. 101 Shanghai Road, Xuzhou 221000, Jiangsu Province, China. lizhengcpu@163.com |
Key Words |
Xiaoyao San; Bioactive constituents; Mechanisms; Non-alcoholic fatty liver disease; Fibrosis |
Core Tip |
Xiaoyao San (XYS) is a classic Chinese medicine prescription. It consists of 8 kinds of herbs, which thus contains abundant bioactive constituents to exert various biological effects. XYS has functions on relief of “liver stagnation and spleen deficiency”, and has long been used to treat liver diseases. Extensive effort has been made in the investigation of effective substances and action mechanisms of XYS against non-alcoholic fatty liver disease, and these achievements could contribute to build up the scientific foundation for its clinical application. |
Publish Date |
2024-10-21 07:03 |
Citation |
<p>Qiu XX, Li Z. Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease. <i>World J Hepatol</i> 2024; 16(10): 1213-1215</p> |
URL |
https://www.wjgnet.com/1948-5182/full/v16/i10/1213.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v16.i10.1213 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345